American Oriental Bioengineering Enters Hong Kong Market - Press Releases

American Oriental Bioengineering Enters Hong Kong Market
April 15 2005
Company Receives License to Market 15 Products
HONG KONG, /PRNewswire-FirstCall/ -- America Oriental Bioengineering Inc., (OTC Bulletin Board: AOBO), a rapidly growing Chinese company which produces and distributes a broad range of pharmaceutical and nutriceutical products, announced today that it has entered the Hong Kong market, and has granted import licenses for 15 out of 16 products that will be marketable in the territory by the Hong Kong Health Department. The Company has also succeeded in obtaining registered trademarks for 9 of its 11 products.
The Company has opened its first retail location, near The Time Square, the most popular shopping centre in Causeway Bay, Hong Kong. American Oriental has also entered into a distribution agreement with Mannings, one of the largest retail shops in Hong Kong. It expects that several of its leading products, including Soy Peptide Tablets, will be sold through the retail chain in the near future. The Company has developed special product packaging for the Hong Kong market designed to enhance the appeal of its products.
"We are excited to enter the lucrative Hong Long market," said Tony Liu, Chief Executive Officer of American Oriental. "We have developed the necessary infrastructure to support our growth there, developing the production, logistics and warehouse facilities to support a large sales operation. We believe that our success in this market will pave the way for us to enter additional markets throughout Asia."
About American Oriental Bioengineering, Inc.
American Oriental Bioengineering, Inc. is a leading Chinese developer and distributor of plant based pharmaceutical and nutriceutical products using natural plants and organic soybeans as raw materials.
The company has two product lines with over 100 products. The first is plant-based pharmaceuticals including Shuanghuanglian Lyophilize Powder Injectible, and Cease-Enuresis Soft Gel. The second is nutraceuticals, including a series of soy protein peptide products and health supplements. These products can be delivered in forms of injectible tablets, capsules, powder, and oral liquids.
American Oriental Bioengineering, Inc.'s product offering is based on three proprietary technologies, creating a unique process to extract soybean peptide more efficiently than using traditional techniques. Cease-Enuresis Soft Gel is the only China SFDA-approved first grade prescription natural plant medicine to treat bed-wetting and incontinence. Shuanghualian Lyophilize Powder Injectible is one of the only two Chinese government approved Huanglian herb based anti-viral injectibles in China. The Company is a leading producer of products in both the nutraceutical and pharmaceuticals areas in China. For more information, visit http://www.bioaobo.com.